semaglutide for kidney failure just got FDA-approved disease. This changes everything., January 2025. The FDA approved semaglutide (Ozempic/Wegovy) for a new indication: reducing kidney disease progression in VisualAbstract: Semaglutide Improves Novo Nordisk's Ozempic Gets FDA

It is designed to support energy metabolism, active performance, and the reduction of tiredness and fatigue

(This is another reason to store your L-Glutamine in a cool dark place)

A simple clinical examination looking for asymmetry, irregular borders, color variation, diameter greater than 6 mm, and change over time or elevated lesion should be suspicious

That rules out both weight and glucose as the primary explanation

Within this mechanistic framework, natural compounds with antioxidant and anti-inflammatory properties, including vitamins C and E, glutathione precursors, CoQ10, L-carnosine, polyphenols including quercetin, resveratrol, and curcumin, and saffron metabolites like crocin and safranal show biological plausibility and preliminary efficacy on biochemical and behavioral endpoints